How to Stop Having a Period: Medical Options

Review the expert medical treatments available for elective or necessary menstrual suppression, covering safety and long-term considerations.

Several well-studied medical options can reduce or eliminate menstrual periods, ranging from everyday hormonal contraceptives taken on a modified schedule to surgical procedures that permanently stop bleeding. The approach that works best depends on your goals, your health history, and whether you want something reversible. Continuous oral contraceptive use, for example, induces amenorrhea in the majority of users within about a year, and hormonal IUDs achieve it in a sizable fraction of users without much daily effort. The landscape is broader than most people realize, and the safety data are more reassuring than many expect.

Continuous or Extended Combined Hormonal Contraceptives

The most accessible route to stopping your period is one you may already have at home. Combined hormonal contraceptives, meaning those that contain both an estrogen and a progestin, were originally packaged with a seven-day placebo or hormone-free interval that triggers a withdrawal bleed. That bleed is not a true period and serves no medical purpose. Skipping the placebo week and starting a new pack immediately is the basis of continuous-use regimens, and it has decades of safety data behind it.

Research shows that continuous oral contraceptive use leads to amenorrhea in roughly 80 to 100 percent of users by 10 to 12 months. Success is not instant, though. In the first few months, unscheduled spotting and light bleeding are common, which is the main reason some people give up before reaching full suppression. The bleeding generally becomes less frequent and lighter as the months go on. A randomized trial comparing continuous versus cyclical pill use found that women on continuous therapy had significantly less moderate-to-heavy bleeding and reported less menstrual pain and better premenstrual well-being.

This approach also works with the contraceptive patch and the vaginal ring: you simply skip the off-week and replace the patch or ring on schedule. The principle is the same. Extended-cycle branded products like Seasonale and Seasonique space withdrawal bleeds to once every three months, which is a middle ground if complete suppression feels like too big a leap. Continuous use just extends that logic to no planned breaks at all.

Hormonal IUDs

Levonorgestrel-releasing intrauterine devices, sold under brand names like Mirena, Liletta, and Kyleena, thin the uterine lining as their primary local effect. The progestin released by the device causes the lining tissue to become inactive and atrophied over time. The result is that many users see dramatically lighter periods, and a meaningful fraction stop bleeding altogether. Rates of amenorrhea vary by device and study, but with the highest-dose Mirena, roughly one in five to one in three users report no periods after the first year.

Hormonal IUDs are appealing for people who want a set-it-and-forget-it method. Once placed, the device works for several years without daily action. It also delivers most of its hormone locally to the uterus, meaning systemic side effects tend to be milder than with pills or injections. The tradeoff is that you cannot guarantee amenorrhea: some people get very light spotting that never fully stops, and others continue to have light but regular periods. If eliminating bleeding entirely is the priority, a hormonal IUD alone may not get you there, though combining it with other strategies is sometimes done under medical guidance.

Implants and Injectables

The etonogestrel subdermal implant (Nexplanon, previously Implanon) is a small rod placed under the skin of the upper arm. It suppresses ovulation and thins the uterine lining, but its effect on bleeding is less predictable than continuous pill use. In studies, about 22 percent of implant users became fully amenorrheic, while roughly a third had infrequent bleeding. The catch is that another subset experienced prolonged or frequent bleeding, and the timing of whatever bleeding did occur was unpredictable. In other words, the implant may stop your period, but it may also give you an irregular one, and there is no reliable way to predict which outcome you will get before trying it.

If you do end up with unfavorable bleeding on an implant, there is some evidence that short courses of tamoxifen can help. One randomized trial found that implant users treated with tamoxifen had about 10 more consecutive amenorrhea days than those given a placebo and took significantly longer to restart bleeding. This is not a mainstream first-line approach, but it signals that options exist if the implant is otherwise working well for you.

Depot medroxyprogesterone acetate (DMPA), the injection given every three months, is one of the more reliable methods for inducing amenorrhea. After a year of use, roughly half of users stop bleeding, and the proportion rises with continued use. The injectable is well studied and widely available, though it carries its own considerations around bone density and a somewhat longer delay in return to fertility after stopping compared with other reversible methods.

Progestin-Only Pills

The progestin-only pill, sometimes called the mini-pill, is a lower-dose option that does not contain estrogen. It is taken daily without a hormone-free interval. Its effect on periods is variable: some users see lighter or absent bleeding, while others do not notice much change. A large survey of progestin-only pill users found that about 80 percent considered their menstrual bleeding acceptable, and among those who had used other hormonal methods before, most said bleeding on the progestin-only pill was similar or better. But “acceptable” does not mean “gone.” If complete amenorrhea is your specific goal, the progestin-only pill is a less reliable route than continuous combined pills or injectables. Its main advantage is that it avoids estrogen, making it an option for people who cannot take estrogen due to migraine with aura, clotting risk, or other contraindications.

Medications for Specific Conditions

When period suppression is part of treating a condition like endometriosis or uterine fibroids, doctors sometimes reach for heavier-duty medications. GnRH agonists (like leuprolide) work by essentially shutting down the hormonal signal from the brain that drives the menstrual cycle, creating a temporary low-estrogen state. This causes periods to stop and can shrink endometriotic lesions. GnRH antagonists achieve a similar effect through a slightly different mechanism. Both are effective at halting menstruation and improving symptoms of endometriosis.

These drugs are not typically used purely for menstrual suppression in otherwise healthy people because the low-estrogen state they create mimics menopause, with side effects like hot flashes, vaginal dryness, and bone loss. “Add-back” therapy, usually a small dose of a progestin or low-dose estrogen given alongside the GnRH agonist, helps mitigate those effects. Even with add-back therapy, though, bone density at the spine can take a hit in some users, particularly adolescents.

For uterine fibroids specifically, selective progesterone receptor modulators like ulipristal acetate have shown the ability to control heavy bleeding and induce amenorrhea while also shrinking fibroids. Data from randomized trials over five years found that the endometrial changes ulipristal caused were both benign and reversible. However, rare but serious liver injury reports have led to restrictions on its use in several countries, so its availability varies depending on where you live.

Surgical Options

If you are done having children and want a permanent or near-permanent solution, two surgical approaches exist. Endometrial ablation destroys the uterine lining using heat, radiofrequency energy, or freezing. It is a relatively quick outpatient procedure, but it does not guarantee amenorrhea. One large study found that only about 23 percent of women achieved complete amenorrhea after global endometrial ablation, and the five-year failure rate was around 16 percent. A more recent analysis of radiofrequency ablation (NovaSure) found amenorrhea in about 37 percent of patients at three months, with roughly 83 percent reporting satisfaction. Being older, having a smaller uterus, and having a thinner endometrium all predict better outcomes. Ablation is not a contraceptive method on its own, and pregnancy after ablation is dangerous, so reliable contraception is still needed.

Hysterectomy, the surgical removal of the uterus, is the only method that stops menstruation with 100 percent certainty. It is the most invasive option but also the most definitive treatment for heavy or unmanageable menstrual bleeding. Modern techniques include laparoscopic and vaginal approaches with shorter recovery times than the traditional open surgery. Hysterectomy is irreversible and eliminates the possibility of pregnancy, so it is generally reserved for people who have exhausted other options or have compelling medical reasons.

Testosterone for Gender-Affirming Care

For transgender men and some nonbinary people, stopping menstruation is often a priority that intersects with gender-affirming hormone therapy. Testosterone, typically administered as an intramuscular injection, suppresses the menstrual cycle in most users. In a study of 74 patients started on low-to-moderate dose testosterone, 55 percent had cessation of menses within six months, and nearly all had stopped bleeding by one year. A separate study found a median time to cessation of about 151 days for patients treated with testosterone alone.

There is individual variability, and the dose of testosterone correlates only loosely with how quickly periods stop. A small percentage of patients need an additional progestin to achieve full cessation. For people who want menstrual suppression but are not ready for or interested in testosterone, the same reversible hormonal methods available to anyone else, including hormonal IUDs, continuous pills, or DMPA injections, can serve as a bridge or standalone solution.

Dealing With Breakthrough Bleeding

The single most common frustration across all hormonal suppression methods is breakthrough bleeding, especially in the first several months. Your uterine lining does not always cooperate on your preferred timeline, and irregular spotting during the transition period is the top reason people abandon suppression attempts. If you are using continuous combined hormonal contraception and experience persistent bleeding, one evidence-backed strategy is to take a short hormone-free interval of about three days when the bleeding starts, then resume active pills. A prospective study found this approach was significantly more effective at stopping the bleeding than just pushing through on active pills. A systematic review confirmed that limited evidence supports this hormone-free interval approach, while other proposed fixes like doxycycline did not help.

The key takeaway with breakthrough bleeding is patience and communication with your provider. Most methods have higher rates of amenorrhea the longer you use them. Quitting at month two because of spotting means missing the months-three-through-twelve window where things often settle down.

Will Suppressing Your Period Affect Future Fertility?

This is the concern that comes up most often, and the evidence is clear: reversible hormonal methods do not impair long-term fertility. A systematic review and meta-analysis found that within 12 months of stopping, pregnancy rates were about 87 percent for former oral contraceptive users, about 85 percent for former IUD users, and about 75 percent for former implant users. These rates are comparable to those seen after stopping condoms or natural family planning. There may be a short delay in the first few months after stopping pills, but 12-month conception rates for former pill users typically fall in the range of 72 to 94 percent, comparable to other methods. Limited data on extended and continuous pill regimens specifically suggest the return to fertility is similar to that of standard cyclical pill use.

The one method where the timeline is a bit different is injectable DMPA, where ovulation can take several months longer to return compared with pills or IUDs. Even then, the delay is temporary rather than permanent. Endometrial ablation and hysterectomy, of course, are in a different category entirely: ablation makes pregnancy dangerous, and hysterectomy makes it impossible.

Bone Health on Long-Term Suppression

Estrogen plays a role in maintaining bone density, so any method that significantly lowers estrogen levels deserves a conversation about bone health. Combined hormonal contraceptives maintain circulating estrogen, so continuous pill use is not associated with bone loss. GnRH agonists, on the other hand, create a deliberately low-estrogen state, and bone mineral density typically drops during use. The decrease usually reverses after stopping, but recovery may be incomplete after prolonged courses. This is why GnRH agonist use is generally time-limited and paired with add-back therapy. DMPA injections are the other method with established bone density concerns, though most guidelines note that the bone loss is reversible after discontinuation for most adult users.

Monthly Periods Are a Modern Phenomenon

One of the most persistent barriers to period suppression is the gut feeling that monthly bleeding must be necessary for health. The evolutionary record pushes back on this pretty hard. Research on populations living in conditions more similar to our ancestors’ suggests that the median number of lifetime menstrual cycles for a woman in such a setting was roughly 100, about a third of what a modern American woman with a few children experiences. For most of human history, women spent the majority of their reproductive years either pregnant or breastfeeding, both of which suppress menstruation naturally. The idea that having a period every 28 days is the biological default is really a product of modern nutrition, smaller family sizes, and shorter breastfeeding durations.

A recent review reinforced that menstruation itself is not required for health, and that women who suppress their periods hormonally still retain the physiological capacity for normal pregnancy-related processes if they later conceive. The withdrawal bleed built into traditional pill packs was a design choice, not a medical necessity. It was included partly to make the pill feel more “natural” and partly in the hope of gaining approval from religious authorities in the 1960s. There is no physiological requirement for a monthly hormonal withdrawal.

Cultural Fears About Amenorrhea

Despite the reassuring evidence, many people feel uneasy about the idea of not having a period. A scoping review of women’s responses to contraceptive-induced menstrual bleeding changes found that altered bleeding was one of the top reasons for contraceptive dissatisfaction and discontinuation globally. In some cultural contexts, amenorrhea was perceived as causing a buildup of “dirty” or “blocked” blood, which in turn was thought to lead to blood clots, fibroids, weight gain, or even infertility and death. None of these beliefs are supported by evidence, but they are widespread and deeply held enough to influence real-world contraceptive choices.

Providers do not always address these fears proactively, which leaves people to fill the gap with folk explanations. If you are considering menstrual suppression and feel a nagging worry that the blood “needs to go somewhere,” it is worth understanding what the suppression is actually doing. Hormonal methods thin the uterine lining so that there is little or no tissue to shed. The blood is not being trapped; it is simply not being produced. The lining stays thin and inactive rather than building up and breaking down every month. That process is no more dangerous than the natural amenorrhea of pregnancy or breastfeeding, which the human body is thoroughly adapted to handle.